Tuesday, December 04, 2012 2:22 pm
News Summary: Baxter to buy Gambro in $2.76B deal
By The Associated Press
THE REASONING: Baxter wants to broader its dialysis product portfolio. Dialysis involves removing blood from a patient, running it through a machine that cleans out impurities and then returning it to the patient's body.
ABOUT BAXTER: Based in Deerfield, Ill., Baxter also makes vaccines, bleeding disorder treatments and intravenous administration sets to deliver medicines and fluids to patients.